Bill

Bill > S653


MA S653

MA S653
Relative to prescription drug pricing


summary

Introduced
01/22/2019
In Committee
01/22/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

For legislation relative to prescription drug pricing. Financial Services.

AI Summary

This bill aims to address the issue of prescription drug pricing by requiring health insurance issuers to disclose to enrollees if they may be subject to an "excess consumer cost burden" - a cost burden greater than what the insurer pays after accounting for rebates. The bill also requires insurers to annually certify that they made available to enrollees at least 50% of the rebates they received. The bill grants the Commissioner of Insurance enforcement authority, including the ability to suspend or revoke an insurer's license for non-compliance. Additionally, the bill applies these requirements to pharmacy benefit managers contracted with the state's Medicaid program.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Accompanied a study order, see S2543 (on 02/18/2020)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...